Citadel Advisors
TOKE

Citadel Advisors’s Cambria Cannabis ETF TOKE Stock Holding History

Citadel Advisors’s Portfolio TOKE Stock Details TOKE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,714
Closed -$16.7K – 15100
2025
Q1 		$16.7K Buy
+3,714
New +$18K ﹤0.01% 13270
2024
Q2 		– Sell
-43
Closed -$265 – 15410
2024
Q1 		$276 Buy
+43
New +$250 ﹤0.01% 14375
2023
Q2 		– Sell
-31,337
Closed -$196K – 15248
2023
Q1 		$196K Sell
31,337
-510
-2% -$3.44K ﹤0.01% 10225
2022
Q4 		$213K Buy
31,847
+15,442
+94% +$111K ﹤0.01% 10008
2022
Q3 		$107K Sell
16,405
-4,073
-20% -$32.1K ﹤0.01% 11028
2022
Q2 		$166K Buy
+20,478
New +$196K ﹤0.01% 10878

Other funds holding TOKE

OMC
Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Citadel Advisors's TOKE Position: Q2 2025 in Review

Citadel Advisors sold out of Cambria Cannabis ETF (TOKE) in Q2 2025, closing a stake of 3,714 shares — an estimated $16.7K sold.

Citadel Advisors first reported a position in TOKE in Q2 2022 and held it in 6 quarters. The position peaked at $213K in Q4 2022. 16 funds tracked by Wall St. Rank hold TOKE as of Q2 2025.

  • Citadel Advisors reported no remaining Cambria Cannabis ETF position as of Q2 2025 after selling out during the quarter.
  • Citadel Advisors sold 3,714 Cambria Cannabis ETF shares in Q2 2025, an estimated $16.7K.
  • Citadel Advisors first reported a position in Cambria Cannabis ETF in Q2 2022 and held it in 6 quarters.
  • Citadel Advisors's Cambria Cannabis ETF position peaked at $213K in Q4 2022.
  • 16 funds tracked by Wall St. Rank held Cambria Cannabis ETF as of Q2 2025.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.